The evidence base supporting the treatment of psychotic depression among older adults is scant. Although the consensus regarding the best therapeutic opinion favors electroconvulsive therapy, most patients, their families, and practitioners will exhaust medication alternatives first. Recent preliminary reports from the Study of the Pharmacotherapy of Psychotic Depression (STOP-PD) suggest a 12-week program of combined antidepressant and antipsychotic pharmacotherapy may achieve remission rates as high as 60%.
|Original language||English (US)|
|Number of pages||3|
|Publication status||Published - Jul 1 2008|
ASJC Scopus subject areas
- Psychiatry and Mental health